IHAM
Integral Health Asset Management’s Zentalis Pharmaceuticals ZNTL Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-1,050,000
| Closed | -$3.18M | – | 107 |
|
|
2024
Q4 | $3.18M | Buy |
+1,050,000
| New | +$3.18M | 0.27% | 70 |
|
|
2024
Q1 | – | Sell |
-250,000
| Closed | -$3.79M | – | 92 |
|
|
2023
Q4 | $3.79M | Sell |
250,000
-200,000
| -44% | -$3.03M | 0.52% | 60 |
|
|
2023
Q3 | $9.03M | Hold |
450,000
| – | – | 1.25% | 30 |
|
|
2023
Q2 | $12.7M | Sell |
450,000
-150,000
| -25% | -$4.23M | 1.57% | 20 |
|
|
2023
Q1 | $10.3M | Sell |
600,000
-150,000
| -20% | -$2.58M | 2.08% | 15 |
|
|
2022
Q4 | $15.1M | Buy |
750,000
+200,000
| +36% | +$4.03M | 3.17% | 7 |
|
|
2022
Q3 | $11.9M | Buy |
550,000
+209,757
| +62% | +$4.54M | 2.31% | 16 |
|
|
2022
Q2 | $9.56M | Buy |
340,243
+125,243
| +58% | +$3.52M | 1.97% | 17 |
|
|
2022
Q1 | $9.92M | Buy |
215,000
+95,000
| +79% | +$4.38M | 2.58% | 11 |
|
|
2021
Q4 | $10.1M | Buy |
120,000
+30,000
| +33% | +$2.52M | 2.79% | 10 |
|
|
2021
Q3 | $6M | Sell |
90,000
-35,000
| -28% | -$2.33M | 1.72% | 21 |
|
|
2021
Q2 | $6.65M | Buy |
125,000
+85,000
| +213% | +$4.52M | 1.83% | 20 |
|
|
2021
Q1 | $1.74M | Buy |
+40,000
| New | +$1.74M | 0.5% | 55 |
|